Summary:

- Elon Musk's Neuralink has received approval from Health Canada to start clinical trials of its brain-computer interface technology in the country. This marks a significant milestone for the company as it aims to develop innovative solutions for treating neurological disorders.

- WiMi Hologram Cloud, a leading provider of augmented reality (AR) and virtual reality (VR) technologies, has also announced plans to accelerate its brain-computer interface (BCI) research and development. This move aligns with the growing interest and advancements in the field of brain-computer interfaces.

- The article highlights the potential of these technologies to revolutionize the way we interact with and understand the human brain, paving the way for new medical treatments and advancements in various fields, including neuroscience, robotics, and human-machine interaction.